Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Not Yet Recruiting

Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)

NCT05746858

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Istituto Nazionale Tumori Fondazione "G. Pascale" IRCCS Naples, Italy

Fonadazione Policlinico Universitario A. Gemelli Roma, Italy

Istituti Fisioterapici Ospitalieri -Istituto Regina Elena Roma, Italy

View Trial Details

Not Yet Recruiting

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

NCT05596097

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Hospital of Lanzhou University Lanzhou, Gansu, China

View Trial Details

Not Yet Recruiting

Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma

NCT05298293

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Polyclinique Bordeaux Nord Aquitaine Bordeaux, France

Clinique Victor Hugo/Centre Jean Bernard/ILC Le Mans, France

Hôpital Privée du Confluent Nantes, France

Centre Hospitalier de St Nazaire Saint-Nazaire, France

View Trial Details

Not Yet Recruiting

First-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOP

NCT05280626

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase I/II Study of Diffuse Large B-cell Lymphoma

NCT04856137

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

NCT04595162

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Not specified

View Trial Details

Completed

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

NCT00006436

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant

NCT03259503

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

NCT01134575

Conditions: Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

NCT04263584

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: University Hospital RWTH Aachen Aachen, Germany

Haematology and Oncology Practice Augsburg, Germany

Klinikum-Bremen-Mitte Bremen, Germany

St.-Johannes-Hospital Dortmund Dortmund, Germany

View all 16 locations

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions